Literature DB >> 33268469

Variation in very preterm extrauterine growth in a European multicountry cohort.

Rym El Rafei1,2, Pierre-Henri Jarreau3,4, Mikael Norman5,6, Rolf Felix Maier7, Henrique Barros8,9, Patrick Van Reempts10, Pernille Pedersen11, Marina Cuttini12, Jennifer Zeitlin3.   

Abstract

OBJECTIVE: Extrauterine growth restriction (EUGR) among very preterm infants is related to poor neurodevelopment, but lack of consensus on EUGR measurement constrains international research. Our aim was to compare EUGR prevalence in a European very preterm cohort using commonly used measures.
DESIGN: Population-based observational study.
SETTING: 19 regions in 11 European countries. PATIENTS: 6792 very preterm infants born before 32 weeks' gestational age (GA) surviving to discharge. MAIN OUTCOME MEASURES: We investigated two measures based on discharge-weight percentiles with (1) Fenton and (2) Intergrowth (IG) charts and two based on growth velocity (1) birth weight and discharge-weight Z-score differences using Fenton charts and (2) weight-gain velocity using Patel's model. We estimated country-level relative risks of EUGR adjusting for maternal and neonatal characteristics and associations with population differences in healthy newborn size, measured by mean national birth weight at 40 weeks' GA.
RESULTS: About twofold differences in EUGR prevalence were observed between countries for all indicators and these persisted after case-mix adjustment. Discharge weight <10th percentile using Fenton charts varied from 24% (Sweden) to 60% (Portugal) and using IG from 13% (Sweden) to 43% (Portugal), while low weight-gain velocity ranged from 35% (Germany) to 62% (UK). Mean term birth weight strongly correlated with both percentile-based measures (Spearman's rho=-0.90 Fenton, -0.84 IG, p<0.01), but not Patel's weight-gain velocity (rho: -0.38, p=0.25).
CONCLUSIONS: Very preterm infants have a high prevalence of EUGR, with wide variations between countries in Europe. Variability associated with mean term birth weight when using common postnatal growth charts complicates international benchmarking. © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  epidemiology; growth; neonatology; statistics

Year:  2020        PMID: 33268469     DOI: 10.1136/archdischild-2020-319946

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  4 in total

1.  Analysis of "true extrauterine growth retardation" and related factors in very preterm infants-A multicenter prospective study in China.

Authors:  Wei Shen; Fan Wu; Jian Mao; Ling Liu; Yan-Mei Chang; Rong Zhang; Zhi Zheng; Xiu-Zhen Ye; Yin-Ping Qiu; Li Ma; Rui Cheng; Hui Wu; Dong-Mei Chen; Ling Chen; Ping Xu; Hua Mei; San-Nan Wang; Fa-Lin Xu; Rong Ju; Chao Chen; Xiao-Mei Tong; Xin-Zhu Lin
Journal:  Front Pediatr       Date:  2022-09-15       Impact factor: 3.569

2.  Never-breastfed children face a higher risk of suboptimal cognition at 2 years of corrected age: A multinational cohort of very preterm children.

Authors:  Carina Rodrigues; Jennifer Zeitlin; Michael Zemlin; Emilija Wilson; Pernille Pedersen; Henrique Barros
Journal:  Matern Child Nutr       Date:  2022-03-16       Impact factor: 3.660

3.  "Aggressive" Feeding of Very Preterm Neonates and Body Mass Index at School Age.

Authors:  Antonios Gounaris; Rozeta Sokou; Martha Theodoraki; Eleni Gounari; Polytimi Panagiotounakou; George Antonogeorgos; Georgios Ioakeimidis; Stavroula Parastatidou; Aikaterini Konstantinidi; Ioanna N Grivea
Journal:  Nutrients       Date:  2021-06-01       Impact factor: 5.717

4.  Randomized Controlled Trial of Two Timepoints for Introduction of Standardized Complementary Food in Preterm Infants.

Authors:  Nadja Haiden; Margarita Thanhaeuser; Fabian Eibensteiner; Mercedes Huber-Dangl; Melanie Gsoellpointner; Robin Ristl; Bettina Kroyer; Sophia Brandstetter; Margit Kornsteiner-Krenn; Christoph Binder; Alexandra Thajer; Bernd Jilma
Journal:  Nutrients       Date:  2022-02-07       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.